Template:AHA SAH BP Guidelines - Revision history

Ostermayer: Marked this version for translation

2026-01-18T02:11:15Z

Marked this version for translation

← Older revision		Revision as of 02:11, 18 January 2026
Line 2:		Line 2:
	<translate>		<translate>

	===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>===		===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>=== <!--T:1-->

			<!--T:2-->
	#No well-controlled studies exist that answer whether BP control influences rebleeding		#No well-controlled studies exist that answer whether BP control influences rebleeding
	#BP should be controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, [[Special:MyLanguage/EBQ:Evidence_Levels\|Level of Evidence B]]).		#BP should be controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, [[Special:MyLanguage/EBQ:Evidence_Levels\|Level of Evidence B]]).
	#Nicardipine, labetalol, and esmolol are appropriate choices for BP control (Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided)		#Nicardipine, labetalol, and esmolol are appropriate choices for BP control (Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided)
	</translate>		</translate>

Ostermayer at 02:11, 18 January 2026

2026-01-18T02:11:00Z

← Older revision		Revision as of 02:11, 18 January 2026
Line 1:		Line 1:
	<languages/>		<noinclude><languages/></noinclude>
	<translate>		<translate>

Ostermayer: Prepared the page for translation

2026-01-18T02:10:38Z

Prepared the page for translation

← Older revision		Revision as of 02:10, 18 January 2026
Line 1:		Line 1:
			<languages/>
			<translate>

	===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>===		===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>===

	#No well-controlled studies exist that answer whether BP control influences rebleeding		#No well-controlled studies exist that answer whether BP control influences rebleeding
	#BP should be controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, [[EBQ:Evidence_Levels\|Level of Evidence B]]).		#BP should be controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, [[Special:MyLanguage/EBQ:Evidence_Levels\|Level of Evidence B]]).
	#Nicardipine, labetalol, and esmolol are appropriate choices for BP control (Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided)		#Nicardipine, labetalol, and esmolol are appropriate choices for BP control (Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided)
			</translate>

Kxl328 at 02:53, 14 March 2016

2016-03-14T02:53:16Z

← Older revision		Revision as of 02:53, 14 March 2016
Line 1:		Line 1:
	===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>===		===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>===
	#No well-controlled studies exist that answer whether BP control influences ~~rebreeding~~		#No well-controlled studies exist that answer whether BP control influences rebleeding
	#BP should be controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, [[EBQ:Evidence_Levels\|Level of Evidence B]]).		#BP should be controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, [[EBQ:Evidence_Levels\|Level of Evidence B]]).
	#Nicardipine, labetalol, and esmolol are appropriate choices for BP control (Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided)		#Nicardipine, labetalol, and esmolol are appropriate choices for BP control (Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided)

Jswartz: /* AHA Aneurysmal SAH BP GuidelinesBederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke....

2015-06-03T22:23:23Z

/* AHA Aneurysmal SAH BP GuidelinesBederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke....

← Older revision		Revision as of 22:23, 3 June 2015
Line 1:		Line 1:
	===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>===		===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>===
	#~~To date, no~~ well-controlled studies exist that answer whether ~~blood pressure~~ control ~~in acute Aneurysmal Subarachnoid Hemorrhage~~ influences rebreeding.		#No well-controlled studies exist that answer whether BP control influences rebreeding
	#~~Blood pressure~~ should be ~~monitored and~~ controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, [[EBQ:Evidence_Levels\|Level of Evidence B]]).		#BP should be controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, [[EBQ:Evidence_Levels\|Level of Evidence B]]).
	#Nicardipine, labetalol, and esmolol are appropriate choices for ~~blood pressure~~ control. Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided.		#Nicardipine, labetalol, and esmolol are appropriate choices for BP control (Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided)

Ostermayer: Created page with "===AHA Aneurysmal SAH BP GuidelinesBederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a..."

2014-07-22T01:16:10Z

Created page with "===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a..."

New page

===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>===
#To date, no well-controlled studies exist that answer whether blood pressure control in acute Aneurysmal Subarachnoid Hemorrhage influences rebreeding.
#Blood pressure should be monitored and controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, [[EBQ:Evidence_Levels|Level of Evidence B]]).
#Nicardipine, labetalol, and esmolol are appropriate choices for blood pressure control. Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided.